Page last updated: 2024-08-16

rivastigmine and Dementia, Vascular

rivastigmine has been researched along with Dementia, Vascular in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	26 (74.29)	29.6817
2010's	7 (20.00)	24.3611
2020's	2 (5.71)	2.80

Authors

Authors	Studies
Diao, XX; Gan, HX; Huang, J; Huang, Y; Li, J; Ma, L; Sun, JM; Tang, Y; Wang, R; Yang, GX; Zhang, L; Zheng, LL	1
Abdul-Rahim, AH; Battle, CE; Hewitt, J; Quinn, TJ; Shenkin, SD	1
Ampil, E; Christopher, S; Kandiah, N; Karanam, AK; Looi, I; Pai, MC; Park, KW; Senanarong, V	1
Johnell, K; Sonde, L	1
Birks, J; Craig, D; McGuinness, B	1
Arizaga, RL; Demey, I; Rojas, G	1
Andreozzi, P; Artini, M; Bechini, F; Cerra, E; De Angelis, R; Ettorre, E; Pontecorvo, ML; Selan, L; Servello, A; Vigliotta, MT; Vulcano, A	1
Chen, YD; Hu, WL; Wang, Y; Yuan, JL; Zhang, J	1
Ballard, C; Barkhof, F; He, Y; Hsu, C; Lane, R; Sauter, M; Scheltens, P; van der Flier, WM; van Straaten, EC; Wu, S	1
Fedorova, IaB; Gavrilova, SI; Kalyn, IaB; Kolykhalov, IV; Selezneva, ND	1
Tang, XC; Wang, J; Zhang, HY	1
Barkhof, F; Lane, R; Scheltens, P; Staekenborg, SS; Su, T; van der Flier, WM; van Straaten, EC	1
Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P	2
Alagiakrishnan, K; Robertson, D; Sclater, A	1
Bonelli, RM	1
Fuchsberger, T; Hampel, H; Möller, HJ	1
Baezner, H; Daffertshofer, M	1
Bochynska, A; Jakubowska, T; Jarosz, H; Jedrzejczak, T; Lojkowska, W; Minc, S; Ryglewicz, D	1
Barkhof, F; Bastos Leite, AJ; Lycklama, G; Scheltens, P; van Straaten, EC	1
Erkinjuntti, T; Feldman, H; Gauthier, S; Rockwood, K; Román, G	1
Antonello, RM; Bava, A; Cazzato, G; Griggio, S; Moretti, R; Torre, P; Ukmar, M	1
Amenta, F; Di Tullio, MA; Tayebati, SK	1
Erkinjuntti, T; Gauthier, S; Román, G	1
Birks, J; Craig, D	1
Román, GC	1
Lane, R; Vincent, S	1
Johannsen, P	1
Farlow, MR	1
Kavirajan, H; Schneider, LS	1
Barkhof, F; Lane, R; Scheltens, P; Staekenborg, SS; van der Flier, WM; van Straaten, EC	1
Gorelick, PB; Nyenhuis, DL	1
Landmark, K; Reikvam, A	1
Anand, R; Hartman, R; Kumar, V; Messina, J; Veach, J	1
Antonello, RM; Cazzato, G; Moretti, R; Torre, P	1

Reviews

16 review(s) available for rivastigmine and Dementia, Vascular

Article	Year
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. The Cochrane database of systematic reviews, 2021, 02-22, Volume: 2 Topics: Activities of Daily Living; Bias; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Donepezil; Galantamine; Humans; Network Meta-Analysis; Nootropic Agents; Physical Functional Performance; Placebos; Randomized Controlled Trials as Topic; Rivastigmine	2021
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. Clinical interventions in aging, 2017, Volume: 12 Topics: Acetylcholinesterase; Activities of Daily Living; Alzheimer Disease; Behavioral Symptoms; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognition; Dementia; Dementia, Vascular; Humans; Parkinson Disease; Rivastigmine	2017
Rivastigmine for vascular cognitive impairment. The Cochrane database of systematic reviews, 2013, May-31, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia, Vascular; Humans; Middle Aged; Nootropic Agents; Phenylcarbamates; Rivastigmine	2013
Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis. European neurology, 2016, Volume: 75, Issue:3-4 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Neuropsychological Tests; Piperidines; Rivastigmine	2016
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta pharmacologica Sinica, 2009, Volume: 30, Issue:7 Topics: Acetylcholine; Alkaloids; Animals; Anti-Inflammatory Agents; Cholinergic Agents; Cholinesterase Inhibitors; Dementia, Vascular; Disease Models, Animal; Donepezil; Galantamine; Humans; Indans; Inflammation; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, Cholinergic; Rivastigmine; Sesquiterpenes; Signal Transduction	2009
[Current therapy of patients with dementia]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dementia; Dementia, Vascular; Donepezil; Dopamine Agents; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Meta-Analysis as Topic; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Placebos; Plant Preparations; Prospective Studies; Rivastigmine; Tacrine; Time Factors	2003
[Subcortical vascular encephalopathy]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amantadine; Brain; Carbamates; Clinical Trials as Topic; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Gait; Humans; Indans; Magnetic Resonance Imaging; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Pilot Projects; Piperidines; Placebos; Prognosis; Risk Factors; Rivastigmine; Time Factors; Tomography, X-Ray Computed; Walking	2003
Rivastigmine in vascular dementia. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6 Topics: Acetylcholinesterase; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Drug Interactions; Humans; Neuroprotective Agents; Phenylcarbamates; Rivastigmine	2004
Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Journal of the neurological sciences, 2004, Nov-15, Volume: 226, Issue:1-2 Topics: Aged; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Parasympathetic Nervous System; Phenylcarbamates; Piperidines; Rivastigmine	2004
Rivastigmine for vascular cognitive impairment. The Cochrane database of systematic reviews, 2005, Apr-18, Issue:2 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Humans; Nootropic Agents; Phenylcarbamates; Rivastigmine	2005
Rivastigmine for subcortical vascular dementia. Expert review of neurotherapeutics, 2005, Volume: 5, Issue:3 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Dementia, Vascular; Humans; Phenylcarbamates; Rivastigmine	2005
[Medical treatment of Alzheimer's disease]. Ugeskrift for laeger, 2006, Oct-02, Volume: 168, Issue:40 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Dementia, Vascular; Disease Progression; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Memantine; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2006
Use of antidementia agents in vascular dementia: beyond Alzheimer disease. Mayo Clinic proceedings, 2006, Volume: 81, Issue:10 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Stroke	2006
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. The Lancet. Neurology, 2007, Volume: 6, Issue:9 Topics: Cholinesterase Inhibitors; Databases, Bibliographic; Dementia, Vascular; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Odds Ratio; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors; Treatment Outcome	2007
Diagnosis and management of vascular cognitive impairment. Current atherosclerosis reports, 2007, Volume: 9, Issue:4 Topics: Central Nervous System Agents; Clinical Trials as Topic; Cognition Disorders; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine	2007
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Jan-31, Volume: 128, Issue:3 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2008

Trials

10 trial(s) available for rivastigmine and Dementia, Vascular

Article	Year
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Current medical research and opinion, 2008, Volume: 24, Issue:9 Topics: Administration, Oral; Aged; Aged, 80 and over; Dementia, Vascular; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Placebos; Prospective Studies; Rivastigmine; Treatment Outcome	2008
[The treatment of Alzheimer's disease in patients with comorbid somatic pathology]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dementia, Vascular; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Somatoform Disorders	2008
Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. Journal of neurology, neurosurgery, and psychiatry, 2010, Volume: 81, Issue:5 Topics: Aged; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Cohort Studies; Dementia, Vascular; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Socioeconomic Factors	2010
Rivastigmine in subcortical vascular dementia: an open 22-month study. Journal of the neurological sciences, 2002, Nov-15, Volume: 203-204 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Behavior; Carbamates; Caregivers; Cholinesterase Inhibitors; Dementia, Vascular; Female; Follow-Up Studies; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Stress, Psychological; Treatment Outcome	2002
The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia. Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1 Topics: Acetylcholine; Aged; Alzheimer Disease; Auditory Perception; Carbamates; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia, Vascular; Female; Frontal Lobe; Humans; Learning; Magnetic Resonance Imaging; Male; Phenylcarbamates; Rivastigmine; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Up-Regulation	2003
Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study. International journal of clinical practice, 2004, Volume: 58, Issue:4 Topics: Aged; Aged, 80 and over; Aspirin; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Drug Therapy, Combination; Female; Humans; Male; Nimodipine; Phenylcarbamates; Psychotic Disorders; Rivastigmine; Treatment Outcome; Vasodilator Agents	2004
Rivastigmine in vascular dementia. International psychogeriatrics, 2003, Volume: 15 Suppl 1 Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Double-Blind Method; Drug Administration Schedule; Humans; Neuropsychological Tests; Phenylcarbamates; Pilot Projects; Rivastigmine; Severity of Illness Index	2003
Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke, 2008, Volume: 39, Issue:2 Topics: Aged; Aged, 80 and over; Aphasia; Basal Ganglia Diseases; Brain Infarction; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia, Vascular; Female; Gait Disorders, Neurologic; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Phenylcarbamates; Prevalence; Reflex, Abnormal; Rivastigmine; Thalamus	2008
An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. European journal of neurology, 2000, Volume: 7, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia, Vascular; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Risk Factors; Rivastigmine; Treatment Outcome	2000
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up. European journal of neurology, 2001, Volume: 8, Issue:4 Topics: Aged; Carbamates; Dementia, Vascular; Female; Follow-Up Studies; Humans; Male; Neuroprotective Agents; Phenylcarbamates; Rivastigmine	2001

Other Studies

9 other study(ies) available for rivastigmine and Dementia, Vascular

Article	Year
Twin drug design, synthesis and evaluation of diosgenin derivatives as multitargeted agents for the treatment of vascular dementia. Bioorganic & medicinal chemistry, 2021, 05-01, Volume: 37 Topics: Acetylcholinesterase; Animals; Cell Survival; Central Nervous System Agents; Cholinesterase Inhibitors; Dementia, Vascular; Diosgenin; Humans; Kelch-Like ECH-Associated Protein 1; Learning; Male; Memory; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotection; NF-E2-Related Factor 2; Protective Agents; Protein Binding; Rats, Sprague-Dawley; Reactive Oxygen Species	2021
Is drug treatment for dementia followed up in primary care? A Swedish study of dementia clinics and referring primary care centres. PloS one, 2013, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Medical Records; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Retrospective Studies; Rivastigmine; Sweden; Treatment Outcome	2013
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina]. Medicina, 2013, Volume: 73, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Child; Child, Preschool; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Dementia, Vascular; Donepezil; Drug Prescriptions; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Young Adult	2013
[Effect of AChE and BuChE inhibition by rivastigmin in a group of old-old elderly patients with cerebrovascular impairment (SIVD type)]. Minerva medica, 2014, Volume: 105, Issue:2 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Disease Progression; Female; Humans; Male; Mental Status Schedule; Neuroprotective Agents; Phenylcarbamates; Rivastigmine	2014
Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman. Journal of the American Geriatrics Society, 2003, Volume: 51, Issue:9 Topics: Aged; Aggression; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia, Vascular; Female; Geriatric Assessment; Humans; Neuroprotective Agents; Phenylcarbamates; Psychomotor Agitation; Rivastigmine; Sexual Behavior; Time Factors	2003
Editorial comment--How to treat vascular dementia? Stroke, 2003, Volume: 34, Issue:10 Topics: Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Treatment Outcome	2003
Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke, 2004, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Carbamates; Clinical Trials, Phase III as Topic; Dementia, Vascular; Humans; Magnetic Resonance Imaging; Middle Aged; Multicenter Studies as Topic; Phenylcarbamates; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Rivastigmine; Sensitivity and Specificity; Single-Blind Method; Thalamus	2004
Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke, 2004, Volume: 35, Issue:4 Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine; Stroke; Terminology as Topic	2004
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. Clinical and experimental hypertension (New York, N.Y. : 1993), 2004, Volume: 26, Issue:4 Topics: Animals; Blood Pressure; Brain; Brain Chemistry; Carbamates; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Dementia, Vascular; Hypertension; Male; Membrane Transport Proteins; Phenylcarbamates; Rats; Rats, Inbred SHR; Rats, Wistar; Rivastigmine; Vesicular Acetylcholine Transport Proteins; Vesicular Transport Proteins	2004